China is changing its patent law with an eye toward ramping up legal protections for drug manufacturers, building on the country's efforts to bolster its intellectual property system. The country is establishing a new system for brand-name manufacturers and generics makers to resolve patent disputes under the changes, which take effect on June 1. Changes to the litigation system could provide more incentives for large drug companies to enter the Chinese market by boosting procedural protections, attorneys say. （China's Patent Law Revamp Promises New Protections for Drugmakers, by Bloomberg Law）
Comment:
The regulations of drug patent protections in the newly revised patent law is a represent of China's efforts in improving IP protection system, conducive to creating a sound business environment.
（Editor Li Xingyi）
（All contents of this newspaper may not be reproduced or used without express permission）